Penumbra

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.

CEO

Adam Elsesser

CEOAdam Elsesser

Employees

4,500

Employees4,500

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

2004

Founded2004

Employees

4,500

Employees4,500

PEN Key Statistics

Market cap

9.90B

Market cap9.90B

Price-Earnings ratio

66.98

Price-Earnings ratio66.98

Dividend yield

—

Dividend yield—

Average volume

314.48K

Average volume314.48K

High today

$254.41

High today$254.41

Low today

$250.30

Low today$250.30

Open price

$253.10

Open price$253.10

Volume

170.78K

Volume170.78K

52 Week high

$310.00

52 Week high$310.00

52 Week low

$198.68

52 Week low$198.68

PEN News

Simply Wall St 3d

Penumbra: Evaluating Valuation After Needham Upgrade and New Growth Catalysts

Penumbra (PEN) has caught investors' attention after Needham upgraded the stock. The upgrade was based on upcoming product launches, strong trial results, and a...

Simply Wall St 5d

How Needham’s Upgrade and Thunderbolt Launch Could Impact Penumbra Investors

Shares of medical device company Penumbra recently advanced after Needham upgraded its rating, citing expectations for stronger growth driven by upcoming produc...

Analyst ratings

81%

of 21 ratings

Buy

81%

Hold

14.3%

Sell

4.8%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.